Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate and Doxorubicin for Refractory Malignant Mesothelioma
NCT00634205Phase 2Completed
- Sponsor
- European Lung Cancer Working Party
- Start
- Jul 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of valproic acid in malignant mesothelioma, sponsored by European Lung Cancer Working Party. Started Jul 2006; status: completed.
02
Drugs
valproic acid
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00634205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634205.